Extract to table
Pull the structured facts out of a document: parties, dates, amounts, obligations.
Extract to table / exhibit-f-confidentiality-data-protection.docx
exhibit-f-confidentiality-data-protection.docx
Parties
Penterra Pharmaceuticals Corp
Harkness LLP
Hargrove LLP
Callahan LLP
Townsend Independent Auditors LLP
Ridgeline Capital Markets LLC
Dates
June 28, 2023
Amounts
$80,000,000
$52,000
$75,000
$40,000
$4,200,000
$1,500,000
$1,230,000
$2,500,000
Obligations
gov Identifier: NCT05928174 IND Number: IND 157823 The parties hereby agree that the following confidentiality and data protection provisions shall govern the treatment, handling, use, and disclosure of Confidential Information exchanged in connection with the CLARION trial and the Agreement
The applicability of a party's obligations as a Receiving Party shall be determined with respect to each item or category of Confidential Information by reference to the party that disclosed such information
7 — Other Defined Terms Capitalized terms used in this Exhibit F that are not otherwise defined herein shall have the meanings ascribed to such terms in the Agreement or in the applicable exhibits and attachments thereto
Prior to being granted access to any Confidential Information, all such personnel and agents must be bound by written confidentiality and non-use obligations that are no less restrictive than those set forth in this Exhibit F
The Receiving Party shall be fully responsible and liable for any breach of the confidentiality obligations of this Exhibit F by any of its personnel, agents, or representatives, and any such breach shall be deemed a breach by the Receiving Party
The Receiving Party shall promptly notify the Disclosing Party of any known or suspected breach by a subcontractor, vendor, or third-party service provider and shall cooperate in the investigation and remediation of any such breach